Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
Australia
Westmead Hospital, Wentworthville, New South Wales Taiwan
China Medical University Hospital, Taichung National Taiwan University Hospital, Taipei Taipei Veterans General Hospital, Taipei